Therapeutic options for treatment of Merkel cell carcinoma

[1]  I. Bechmann,et al.  Assay-based response evaluation in head and neck oncology: requirements for better decision making , 2010, European Archives of Oto-Rhino-Laryngology.

[2]  S. Swerdlow,et al.  Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors , 2009, International journal of cancer.

[3]  A. Dietz,et al.  Single Tissue Samples from Head and Neck Squamous Cell Carcinomas are Representative Regarding the Entire Tumor’s Chemosensitivity to Cisplatin and Docetaxel , 2009, Oncology Research and Treatment.

[4]  C. Gomez-Fernandez,et al.  Management of the neck in Merkel cell carcinoma of the head and neck: University of Miami experience , 2008, Head & neck.

[5]  E. Baldini,et al.  Analysis of Radiation Therapy for the Control of Merkel Cell Carcinoma of the Head and Neck Based on 36 Cases and a Literature Review , 2008, Ear, nose, & throat journal.

[6]  M. Werner,et al.  Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. , 2008, Cancer research.

[7]  Arash Mostaghimi,et al.  Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. , 2008, Journal of the American Academy of Dermatology.

[8]  P. Nghiem,et al.  Merkel cell carcinoma: more deaths but still no pathway to blame. , 2007, The Journal of investigative dermatology.

[9]  A. Psyrri,et al.  Cisplatin-Based Chemotherapy for Merkel Cell Carcinoma of the Skin , 2006, Cancer investigation.

[10]  V. Gebski,et al.  MERKEL CELL CARCINOMA: IMPROVED OUTCOME WITH ADJUVANT RADIOTHERAPY , 2005, ANZ journal of surgery.

[11]  D. Coit,et al.  Merkel cell carcinoma: prognosis and treatment of patients from a single institution. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  T. Toubiana,et al.  Analyse de la littérature , 2004 .

[13]  Yuan Cheng,et al.  Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Gillenwater,et al.  Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. , 2001, Archives of otolaryngology--head & neck surgery.

[15]  L. Stitt,et al.  Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  R. W. Miller,et al.  Merkel cell carcinoma and melanoma: etiological similarities and differences. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  A. Sulkes,et al.  The role of radiation therapy and chemotherapy in the treatment of merkel cell carcinoma , 1997, Cancer.

[18]  P. Dumont,et al.  Evaluation of a prediction model of cisplatin dose based on total platinum plasma concentration. , 1996, European journal of cancer.

[19]  J. Kearsley,et al.  The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. , 1995, International journal of radiation oncology, biology, physics.

[20]  S. Pendlebury,et al.  Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. , 1995, International journal of radiation oncology, biology, physics.

[21]  D. Kerr,et al.  Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion. , 1993, Cancer research.

[22]  P. Leboit,et al.  Pagetoid Intraepidermal Spread in Merkel Cell (Primary Neuroendocrine) Carcinoma of the Skin , 1992, The American journal of surgical pathology.

[23]  T. B. Miller,et al.  Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A , 1990, Cell.

[24]  R. Benjamin,et al.  Chemotherapy for metastatic merkel cell carcinoma. Review of the M. D. Anderson hospital's experience , 1988, Cancer.

[25]  J. Bennett,et al.  Chemotherapy for metastatic merkel cell carcinoma , 1985, Cancer.

[26]  A. Levine,et al.  Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells , 1979, Cell.

[27]  D. Lane,et al.  T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.

[28]  D. Lowy,et al.  Getting stronger: the relationship between a newly identified virus and Merkel cell carcinoma. , 2009, The Journal of investigative dermatology.

[29]  G. Noël,et al.  [Merkel cell carcinoma, role of radiotherapy and literature review]. , 2009, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[30]  B. Thiers,et al.  Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma , 2009 .

[31]  J. Becker,et al.  Merkel cell carcinoma , 2008, Cellular and Molecular Life Sciences.

[32]  Nicole C Hodgson,et al.  Merkel cell carcinoma: Changing incidence trends , 2005, Journal of surgical oncology.

[33]  M. Ming,et al.  Merkel cell carcinoma , 2004, Current treatment options in oncology.

[34]  C. Toker.  Trabecular carcinoma of the skin. , 1972, Archives of dermatology.